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Introduction
MRSA infection is a major health care problem. In 2008,
as a component of a general strategy for infection pre-
vention, a program to control MRSA was implemented
in our ICU, consisting in pre-emptive isolation, rapid
screening tests for identification of MRSA carriers and
targeted decolonization with nasal mupirocin in addition
to antiseptic body bathing. At the same time, screening
of at-risk patients along with targeted isolation and anti-
septic body washing was implemented in general wards.
Objectives
To evaluate the compliance with this strategy and the suc-
cess of nasal eradication. To assess MRSA colonization
prevalence and transmission rate evolution. To analyse
this strategy impact on MRSA rates, oxacillin-resistance
and anti-MRSA antibiotic consumption.
Methods
We retrospectively analyzed all patients admitted to our
ICU between 2010 and 2014. Data collected included
demographics, nasal swab, isolation measures and nasal
mupirocin prescription, staphylococcus aureus isolates
and pattern of sensibility along with consumption of
vancomycin, linezolid, tigecycline and daptomycin.
Results
1753 admissions and 3149 nasal swabs were analyzed
during the study period. On admission 98% (1720/1753)
of patients had a nasal swab taken. We found a docu-
mented order for contact isolation in 92,5% of the posi-
tive (colonized) patients. Only 72,4% (126/174) of
colonized patients started nasal mupirocin in the ICU.
After treatment with nasal mupirocin 31/92 (33,7%) of
patients had a negative nasal swab, and this eradication
rate improved from 31,3% in 2010 to 63,6% in 2014.
Prevalence of MRSA colonization on admission was
8,4%, 11,7%, 5,3%, 3,6% and 5,1% respectively from 2010
to 2014. Transmission rate was 5,2 new cases/1000
patient-days in 2010 and 5,1 in 2014. MRSA incidence
was 7.39 isolates/1000 patient-days in 2011, 2.72 in 2012,
3.91 in 2013 and 2.32 in 2014. The percentage of oxacil-
lin-resistance decreased from 59.3% in 2011 to 18.2 in
2014. Anti-MRSA antibiotic consumption was 1547
DDD/1000 patients in 2011, 1330 in 2012, 649 in 2013
and 815 in 2014
Conclusions
MRSA incidence and methicillin resistance is decreasing
in our ICU and this may be related to our strategy to
control MRSA along with a multidirectional infection
prevention approach. The declining in consumption of
anti-MRSA antibiotics may reflect not only a reduction
in clinical infections but also less MRSA coverage in the
empirical treatment of nosocomial infections. The com-
pliance with the strategy has improved but the nasal era-
dication rate remains low. Transmission rate of MRSA
remains higher than expected, signaling that more efforts
must be done in enhancing transversal infection preven-
tion measures.
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